# Assessment of distinct effects of Parinari curatellifolia Planch.ex Benth Ethanolic leaf extract on glucose transport in different cell types

## TL;DR

This study shows that a plant extract affects glucose transport differently in fat and intestinal cells, which may explain its traditional use for diabetes.

## Contribution

The study reveals cell-type-specific effects of P. curatellifolia extract on glucose transport and highlights its potential antidiabetic mechanism.

## Key findings

- PCE inhibited insulin-stimulated glucose transport in 3T3-L1 adipocytes at 100 µg/mL.
- PCE increased glucose transport in Caco-2 cells by 2-fold and increased GLUT1 levels.
- The effects in Caco-2 cells were independent of Akt, AMPK, or p38 pathways.

## Abstract

Extracts of Parinari curatellifolia Planch.ex Benth have been used as a traditional medicine in Sub-Saharan Africa for the management of various ailments including diabetes and has been shown to reduce plasma glucose levels in rat models of diabetes. Treatment of a range of mammalian cell lines with P. curatellifolia ethanolic leaf extract (PCE) for 24–48 h, typically between 0 and 100 µg/mL, revealed different actions: in 3T3-L1 adipocytes, PCE markedly inhibited insulin-stimulated glucose transport (50% inhibition at 100 µg/mL), whereas by contrast PCE-treatment of Caco-2 cells, a model of the intestinal epithelia at the same concentration, increased glucose transport ∼2-fold. This effect was accompanied by increased glucose transporter-1 (GLUT1) levels but is independent of changes in the level of Akt, Adenosine monophosphate-activated protein kinase (AMPK) or p38. Our data suggest that the antidiabetic effects of extracts of P. curatellifolia may arise by increased absorption of glucose from the gut and thus distribution to other cells/tissues. Our data further highlight the importance of screening metabolic actions of plant extracts against multiple cell lines, as these can often exhibit distinct cell-type-specific responses, and further suggest that relatively low doses of PCE (up to 100 µg/mL) could warrant investigation in in vivo models of disease.